# Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy

> **NCT01475188** · PHASE4 · COMPLETED · sponsor: **Ministry of Science and Higher Education, Poland** · enrollment: 41 (actual)

## Conditions studied

- Immunotherapy
- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Allergovit
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01475188
- **Lead sponsor:** Ministry of Science and Higher Education, Poland
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2010-10
- **Final completion:** 2010-12
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2011-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475188, "Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01475188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*